Loading...
Freedom of Information (FOI) NHS Lothian | Our Organisation

Request and Response Register

NOTE: 100 recent requests are displayed below. Use search to find older requests.
Freedom of Information Request Reference: 11089
Date Received: 27/01/2026
Summary:
I am interested in the waiting time for people thought to have neurodegenerative conditions such as Alzheimer's or other dementias, What is the longest time someone on such a list has had to wait? How many people are on the list?
Date of Response: 24/02/2026
View Response: 11089.pdf
Freedom of Information Request Reference: 11088
Date Received: 27/01/2026
Summary:
Please can you provide the following for your respective HB: 1. The average ‘injury to spine, decompression surgery interval’ (or be differentiated from general life saving surgery). 2. The number of secondary referrals (%) necessary.
Date of Response: 26/02/2026
View Response: 11088.pdf
Freedom of Information Request Reference: 11087
Date Received: 26/01/2026
Summary:
Q1. How many patients has your Trust treated in the past 12 months (January - December 2025) for Chronic Lymphocytic Leukaemia (CLL)? In case you do not treat CLL, which other Trust do you refer patients needing treatment to? Q2. How many Chronic Lymphocytic Leukaemia (CLL) patients have been treated by the Trust in the past 6 months on the following treatments: •BR (bendamustine + rituximab) •Brukinsa (zanubrutinib) •Calquence (acalabrutinib) •Calquence (acalabrutinib) + Gazyva (obinutuzumab) •Calquence (acalabrutinib) + Venclyxto (venetoclax) •Calquence (acalabrutinib) + Venclyxto (venetoclax) + Gazyva (obinutuzumab) •FCR (fludarabine + cyclophosphamide + rituximab) •Fludarabine Monotherapy •Gazyva (obinutuzumab) + chlorambucil •Imbruvica (ibrutinib) •Venclyxto (venetoclax) •Venclyxto (venetoclax) + Gazyva (obinutuzumab) •Venclyxto (venetoclax) + rituximab •Zydelig (idelalisib) + rituximab •Imbruvica (Ibrutinib) +Venclyxto (venetoclax) •Any other systemic anti-cancer therapy Q3. How many Chronic Lymphocytic Leukaemia (CLL) patients have received treatment for relapsed/refractory CLL in the past 6 months with the following: •Brukinsa (zanubrutinib) •Calquence (acalabrutinib) •Imbruvica (ibrutinib) •Venclyxto (venetoclax) •Zydelig (idelalisib) + rituximab •Any other systemic anti-cancer therapy Q4. If your Trust does treat Chronic Lymphocytic Leukaemia patients, do you currently participate in any ongoing clinical trials for the treatment of CLL? If yes, please can you provide details of the ongoing trials.
Date of Response: 24/02/2026
View Response: 11087.pdf
Freedom of Information Request Reference: 11086
Date Received: 26/01/2026
Summary:
1) Do you have a shared care framework for GPs in your area about shared care agreements with third party providers for the treatment and management of ADHD? 2) If the answer to 1 above is yes, please provide a copy of your most up to date documents related to shared care agreements with third party providers for the treatment and management of ADHD 3) If the answer to 1 above is no, please provide a copy of any policies or instructions sent to GPs in your area about shared care agreements with third party providers for the treatment and management of ADHD
Date of Response: 24/02/2026
View Response: 11086.pdf
Freedom of Information Request Reference: 11085
Date Received: 26/01/2026
Summary:
As the Board will be aware, the Supreme Court judgement of April last year defined that the protected characteristic of sex in relation to the Equality Act 2020 was biological and binary. This has consequences for NHS Boards in Scotland who have tended to treat ‘gender’ and ‘sex’ as interchangeable, both as an employer and as a service provider. Indeed, on 30th September 2025 Gillian Russell, Director NHS Scotland Health Workforce, wrote to all Boards and advised: Following the Supreme Court Ruling regarding the definition of ‘woman’ in the Equality Act 2010, my colleagues wrote to you on 30 May to bring to your attention to guidance for public bodies https://www.gov.scot/publications/uk-supreme-court-ruling-on-meaning-of-sex-inequality-act-update/. I am now writing to you to reinforce that message, and the importance of Boards ensuring that the law is followed, and the Supreme Court judgement implemented. It is important that Boards, as independent legal entities, seek their own legal advice and are confident that they are complying with the judgement and with all relevant legislation and regulations. I have been unable to find any reference in the Corporate Risk Register to the implications of the Board ensuring it gets legal advice and ensures compliance with the law as an employer as well as a service provider. Given the Employment Tribunal case of 2025 and ongoing and involving NHS Fife and Ms Peggie, this seems remiss. In terms of the Freedom of Information [Scotland] Act 2002, I write to ask for sight of all Board papers, emails and internal correspondence setting how NHS Lothian has responded to Ms Russell’s letter of 30th September 2025, what legal advice the Board has taken, what actions the Board has planned to ensure compliance with the law, and what conclusions were reached on entering the risks around this issue and why it was not entered in the Corporate Risk Register.
Date of Response: 27/02/2026
View Response: 11085.pdf
Freedom of Information Request Reference: 11084
Date Received: 26/01/2026
Summary:
For each calendar year from 2010 to 2024: • Number of recorded cases of postpartum haemorrhage (ICD-10 O72.x) • Number of recorded cases of placenta praevia (ICD-10 O44.x) • Number of recorded cases of placenta accreta spectrum disorders (O43.21–O43.23) • Number of caesarean sections (elective and emergency, if recorded) If available, I would also be grateful for: • Number of peripartum hysterectomies • Number of deliveries requiring blood transfusion
Date of Response: 05/03/2026
View Response: 11084.pdf
Freedom of Information Request Reference: 11083
Date Received: 26/01/2026
Summary:
I do not accept that the application of Sections 38(1)(a)/(b) and 30(b)/(c) justifies a blanket refusal of the information requested. My request concerns governance and complaints-handling processes relating to complaint ~~~~~, not the disclosure of personal medical records. While I acknowledge that Section 38 may apply to certain personal data, this does not exempt NHS Lothian from its duty to consider partial disclosure. The response does not demonstrate that NHS Lothian has appropriately separated disclosable information (e.g. professional roles/job titles, categories of evidence reviewed, timescale management records, and complaint-handling procedures/flowcharts) from any exempt personal information, nor does it explain why anonymised disclosure is not possible. I also dispute the reliance on Section 30(b) and (c). The response does not set out specific and credible prejudice that would be likely to result from disclosure, nor does it evidence the required public interest assessment. In particular, it is unclear how disclosure of high-level governance and process information could prejudice the effective conduct of public affairs, especially where the Board has issued final complaint responses and signposted SPSO escalation. Accordingly, I request that the reviewer reassesses the exemptions applied and confirms what information can be disclosed, including any information that can be provided in anonymised form and any process documentation held.
Date of Response: 24/02/2026
View Response: 11083.pdf
Freedom of Information Request Reference: 11082
Date Received: 26/02/2026
Summary:
1. The eligibility criteria for patients to be referred to the service, and any exclusion criteria that would prevent a referral being accepted. 2. Who is permitted to refer patients to the service (e.g. GP, consultant, allied health professional, self-referral), and how patients or carers contact the service to request an appointment or assessment. 3. The current staffing establishment for the service, including job titles/roles and whole-time equivalent (WTE) for each role. 4. The number of referrals received by the service in each of the last three financial years, including the number of referrals declined in each year. 5. Which clinical systems used (eg EMIS, Vision etc) are used by the service to record patient information.
Date of Response: 24/02/2026
View Response: 11082.pdf
Freedom of Information Request Reference: 11081
Date Received: 26/01/2026
Summary:
I would like to request the following information your organisation may hold regarding incidents of spiking: The number of recorded incidents of suspected spiking cases from October 2021 – September 2025, broken down by month where possible. Where available, provide a breakdown of the information, such as grouped data or percentages: Type of spiking methods – needling, drink spiking, food spiking, vape spiking and any other means Gender – Male, Female, Non-binary, Not disclosed, Other Age group of individuals at the time of alleged spiking – below 18 18 to 24 25 to 34 35 to 44 45 and above Setting/location type where spiking took place (bar, nightclub, private residence, university accommodation, others) Copies of or link to any guidance, protocols, or policies your organisation has for responding to suspected spiking incidents.
Date of Response: 06/03/2026
View Response: 11081.pdf
Freedom of Information Request Reference: 11078
Date Received: 22/01/2026
Summary:
• The total number of diagnostic tests performed for Group A Streptococcus (Strep A) during the calendar years of 2024 and 2025, broken down by test type. • If available, please indicate the type of tests used (e.g., rapid antigen, rapid molecular, culture). • Any associated data on positivity rates for these tests, if recorded.
Date of Response: 26/02/2026
View Response: 11078.pdf
Freedom of Information Request Reference: 11077
Date Received: 21/01/2026
Summary:
1. What is the total annual cost to your health board for all food for patients. (Please can you provide a breakdown for the last five years). 2. What is the top five food products for patients that your health board spends the most money on annually. (Please could you provide that information for the last five years). 3. What food product for patients does your health board spend the least money on annually? (Please provide that information for the last five years). 4. What five most frequent meals provided to patients in your health board.
Date of Response: 26/02/2026
View Response: 11077.pdf
Freedom of Information Request Reference: 11075
Date Received: 21/01/2026
Summary:
I am seeking information about the number of critical incidents declared by all hospitals within your NHS trust during two specific one-year periods: - Period 1: 13th November 2023 - 12th November 2024 - Period 2: 13th November 2024 - 12th November 2025
Date of Response: 17/02/2026
View Response: 11075.pdf
Freedom of Information Request Reference: 11074
Date Received: 21/01/2026
Summary:
I am writing to you under the Freedom of Information (Scotland) Act 2002 to request information relating to the use of off-contract locum staff within NHS Lothian. For the purposes of this request, “off-contract locum spend” should be interpreted as expenditure on temporary clinical staff not sourced via national, regional, or framework agreements. This includes, but is not limited to, non-framework agencies, direct engagements outside approved contracts, or ad-hoc arrangements. Information Requested Please provide the following information for NHS Lothian: 1. Financial Year 2024/2025 The total monetary value (£) of off-contract locum spend incurred between 1 April 2024 and 31 March 2025. 2. Financial Year 2025/2026 (Part Year) The total monetary value (£) of off-contract locum spend incurred between 1 April 2025 and 31 December 2025 (end of Q3). Breakdown (If Available) Where the information is already held in a reportable format, I would be grateful if the totals above could be broken down by: • Clinical staff group (e.g., Medical & Dental, Nursing & Midwifery, AHPs) • Care setting (e.g., Acute, Community, Mental Health) • Directorate, service, or hospital site Please note this breakdown is optional and should only be provided where it does not exceed the cost/time limits set out under FOISA. Additional Context (If Held) If available within existing records, please also confirm: • Whether NHS Lothian operates a formal framework or preferred supplier list for locum staffing. • Whether any internal controls, caps, or approval processes apply specifically to off-contract locum engagements.
Date of Response: 26/02/2026
View Response: 11074.pdf
Freedom of Information Request Reference: 11073
Date Received: 21/01/2026
Summary:
Please can I have a copy of any form of recorded communication (such as emails or reports) between your health board and the Scottish government relating to the creating of a new network of walk-in General Practice services.
Date of Response: 02/03/2026
View Response: 11073.pdf
Freedom of Information Request Reference: 11072
Date Received: 21/01/2026
Summary:
1/ How many referrals have been made to the board's sleep service for suspected sleep apnea in 2024, 2025 and 2026 to date. 2/ What was the average waiting time from referral to treatment for sleep apnea in 2024, 2025 and 2026 to date. 3/ How many deaths have been recorded in the health board region with sleep apnea as either a contributing factor or a comorbidity, in each of the last five years, including 2024 to date.
Date of Response: 02/03/2026
View Response: 11072.pdf
Freedom of Information Request Reference: 11071
Date Received: 21/01/2026
Summary:
Please could I have the following information for 2024/25 and 2025/2026 to day - broken down by year: 1) How many referrals have been made by GPs for assessments for ADHD for a) children b) adults 2) How many referrals have been made by GPs for assessments for autism for a) children b) adults In the case that the board does not specify the condition for each referral, could you provide the general referral numbers for a) children and b) adults across these years. 3) How long is the waiting time in weeks for an ADHD assessment for a) children b) adults 4) How long is the waiting time in weeks for an autism assessment for a) children b) adults In the case that the board does not specify the condition for each referral, could you provide the general referral numbers for a) children and b) adults across these years.
Date of Response: 05/03/2026
View Response: 11071.pdf
Freedom of Information Request Reference: 11070
Date Received: 21/01/2026
Summary:
A) Does your Trust have a process in place for patients who are unable to fit in, or use, an MRI machine but who may need a MRI scan? If so, what is this process? B) Does your Trust send patients who may need an MRI scan who meet the criteria of being unable to use your Trusts’ scanners above, to zoos or vets? C) For the last 3 full calendar years (2023/24/25) and for as much of 2026 as possible please, how many patients have been sent to zoos or vets for MRI scans? D) Does your Trust pay other facilities such as zoos or vets for the use of their MRI machines?
Date of Response: 18/02/2026
View Response: 11070.pdf
Freedom of Information Request Reference: 11069
Date Received: 20/01/2026
Summary:
Please provide the following information: • The total number of Influenza A/B, COVID 19, and RSV diagnostic tests performed by your Trust during the calendar years of 2024 and¬¬¬ 2025, broken down by test type. • If available, please indicate the type of tests used (e.g., rapid antigen, rapid molecular, RT PCR). • Any associated data on positivity rates for these tests, if recorded.
Date of Response: 26/02/2026
View Response: 11069.pdf
Freedom of Information Request Reference: 11068
Date Received: 20/01/2026
Summary:
I am conducting a cost-efficiency review on the use of Ultraviolet light disinfection -UV-C in the trust. I would like to request the following information: • Does the trust use UV-C for surface disinfection • How many UV-C machines has the trust purchased • What were the dates these were purchased • How many were being used in 2025 • What is the total spend on UV-C machines
Date of Response: 23/02/2026
View Response: 11068.pdf
Freedom of Information Request Reference: 11067
Date Received: 20/01/2026
Summary:
car parking permit scoring process 1.) What questions in the 2026/2027 application form relate to each of these application criteria? 2.) The scoring guidelines and points breakdown associated with each section. And how many points are needed for a successful application? 3.) How many people are responsible for scoring each application? Do they work individually? Are applications scored independently and anonymously? If not, what are the reason/s for this? 4.) What specific processes are in place that ensures equity and transparency in the application process?
Date of Response: 26/02/2026
View Response: 11067.pdf
Freedom of Information Request Reference: 11066
Date Received: 19/01/2026
Summary:
Please provide the following information relating to your sexual health service’s provision of intrauterine devices (IUDs/coils): 1. Any current written policies, clinical guidelines, or eligibility criteria governing access to IUD/coil fitting within your service. 2. Whether IUDs/coils are provided by your service for non-contraceptive purposes (including but not limited to management of dysmenorrhoea, menorrhagia, endometriosis or cycle regulation). 3. Whether eligibility for IUD/coil fitting is contingent on pregnancy risk, sexual activity with men, or use for contraception. 4. Any guidance provided to clinicians on assessing patient eligibility where contraception is not required for pregnancy prevention.
Date of Response: 16/02/2026
View Response: 11066.pdf
Freedom of Information Request Reference: 11065
Date Received: 19/01/2026
Summary:
Please provide any information held by East Lothian Health & Social Care Partnership from January 2023 to the present regarding the cessation, suspension, withdrawal, or refusal of shared care arrangements for ADHD medication for patients formally diagnosed by qualified clinicians using DSM 5 criteria or NICE compliant assessment guidelines. Please include: 1. Communications (internal or external) issued by or received by East Lothian HSCP relating to changes in shared care prescribing for ADHD medication. 2. Policies, guidance, protocols, or instructions circulated to GP practices, mental health teams, or pharmacy services regarding shared care prescribing for ADHD. 3. Meeting minutes, reports, briefing papers, or decision making documents that refer to ending, altering, or reviewing shared care arrangements for ADHD medication in East Lothian. 4. Any data held on the number of GP practices in East Lothian that have ceased, paused, or declined shared care requests for ADHD medication since 2023.
Date of Response: 17/02/2026
View Response: 11065.pdf
Freedom of Information Request Reference: 11002
Date Received: 06/01/2026
Summary:
1. The number of patients being removed from an NHS waiting list due to attending or being admitted at the private sector. [Please note: I am referring to patients who have chosen to pay for private treatment; not patients that are being treated as NHS patients at a private healthcare clinic]. I would like this information for the last 8 calendar years (2019, 2020, 2021, 2022, 2023, 2024, 2025 and 2026).
Date of Response: 06/03/2026
View Response: 11002.pdf
Freedom of Information Request Reference: 10987
Date Received: 30/12/2025
Summary:
I request information regarding this Health Board’s specific expenditure, implementation, and oversight of Microsoft 365 (M365) and associated IT systems. 1. Local Expenditure • The total annual spend by your Board on Microsoft 365 licensing and supplementary digital tools (e.g., Power BI, advanced security add-ons, or external consultancy for M365 migration) for the financial years 2022/23, 2023/24, and 2024/25. • Please specify if any of this funding was drawn from "core" board budgets versus specific "digital transformation" grants provided by the Scottish Government or NHS National Services Scotland (NSS). 2. Implementation and Staffing • The number of staff members within the Board’s IT/Digital department whose primary role is the administration, security, or "adoption" (training) of the M365 platform. • Details of any local "Digital Maturity" assessments or internal reviews conducted by the Board to measure the effectiveness of the M365 rollout since 2022. 3. Oversight and Risk Management • Minutes or summary reports from the Board’s Information Governance Committee (or equivalent) from the last 12 months where "Microsoft 365," "Cloud Migration," or "Data Sovereignity" were substantive agenda items. • A copy of the Board’s current Data Protection Impact Assessment (DPIA) specifically for the use of Microsoft 365 (specifically including Teams and OneDrive) for clinical or patient-identifiable data. 4. Third-Party Support • Details of any third-party IT managed service providers (MSPs) or consultants currently contracted by the Board to support the M365 environment, including the name of the provider and the annual contract value.
Date of Response: 06/03/2026
View Response: 10987.pdf
Freedom of Information Request Reference: 11064
Date Received: 19/01/2026
Summary:
Please provide any information held by NHS Lothian from January 2023 to the present regarding the cessation, suspension, or withdrawal of shared care arrangements for ADHD medication for patients formally diagnosed by qualified clinicians using DSM 5 criteria or NICE compliant assessment guidelines. Specifically, please include: • Any internal or external communications circulated to GP practices, clinical teams, pharmacy services, or Scottish Government bodies regarding changes to shared care for ADHD medication. • Any policies, guidance, or instructions relating to alterations of shared care prescribing arrangements for ADHD medication. • Any meeting minutes, reports, or decision-making documents that reference ending or changing shared care responsibilities. • Any data held on the number of GP practices that have stopped accepting shared care for ADHD medication.
Date of Response: 02/03/2026
View Response: 11064.pdf
Freedom of Information Request Reference: 11063
Date Received: 19/01/2026
Summary:
I request the following information relating to IUD/coil provision within your sexual health service: 1. The average and median waiting time for IUD/coil fitting appointments over the last 12 months. 2. Whether waiting times differ depending on the stated reason for fitting (e.g. contraception vs non-contraceptive medical use). 3. Whether patients seeking IUDs/coils for non-contraceptive purposes are routinely referred elsewhere (e.g. GP or gynaecology services), and if so, to which services. 4. Any prioritisation criteria used when allocating IUD/coil fitting appointments.
Date of Response: 24/02/2026
View Response: 11063.pdf
Freedom of Information Request Reference: 11062
Date Received: 19/01/2026
Summary:
1. All-cause deaths recorded by your organisation (or within the area you cover) for each year from 2015 to 2025, inclusive. 2. For each year, please provide a breakdown of all-cause deaths by the following categories: o Sex o Ethnicity o Age group (please specify the age ranges used) 3. For each category above, I would also like a summary of the causes of death, ideally coded using ICD-10 (or your organisation’s standard classification), and with counts of deaths per cause.
Date of Response: 24/02/2026
View Response: 11062.pdf
Freedom of Information Request Reference: 11060
Date Received: 16/01/2026
Summary:
1. Please provide the following information in relation to nursing* staff sickness absence within the NHS Board for each of the financial years 2024/25 and 2025/26 year to date at 31 December 2025: The number by sickness absence reasons for: a) sickness absence episodes b) working days lost c) number of staff absent 2) Please provide the following information in relation to Agenda for Change bands 5-9 nursing* staff sickness absence within the NHS Board for each of the financial years 2024/25 and 2025/26 year to date at 31 December 2025: The number by sickness absence reasons for: a) sickness absence episodes b) working days lost c) number of staff absent 3) Please provide the following information in relation to Agenda for Change bands 2-4 nursing* staff sickness absence within the NHS Board for each of the financial years 2024/25 and 2025/26 year to date at 31 December 2025: The number by sickness absence reasons for: a) sickness absence episodes b) working days lost c) number of staff absent 4. Please provide the sickness absence rate for nursing staff in the NHS Board at 31 March for each of the financial years 2024/25 and 2025/26 year to date at 31 December 2025 for a) all nursing staff b) Agenda for Change bands 5-9 and c) Agenda for Change bands 2-4.
Date of Response: 17/02/2026
View Response: 11060.pdf
Freedom of Information Request Reference: 11052
Date Received: 15/01/2026
Summary:
1. Monthly activity data (earliest records held to latest available) For each calendar month from the earliest date for which records are held up to the most recent complete month, please provide: - The number of referrals received - The number of first (initial) assessment appointments offered - The number of first (initial) assessment appointments completed - The total number of patients discharged If the above data is held in a tabular format internally, I would prefer it provided in the same or similar tabular form. 2. Current waiting list snapshot (most recent month available) As of the most recent reporting date available, please provide: - The total number of people currently waiting for a first appointment - The referral month and year of the patients currently being offered first appointments - The number of patients recorded as “Did Not Attend” (DNA) for first or second appointments in the most recent complete month
Date of Response: 24/02/2026
View Response: 11052.pdf
Freedom of Information Request Reference: 11040
Date Received: 14/01/2026
Summary:
1. Digital Dictation ● Name of supplier & product ● Number of user licences ● Procurement method (e.g., framework) ● Contract start date ● Contract expiry date (please specify fixed end date vs option to extend/rolling contract) ● Total contract value (if available) ● Integration with PAS/EPR (please specify if outbound only – e.g., patient demographics, clinic work list – or outbound and inbound, e.g., document return) ● Key internal stakeholder role/title ● Desired features not currently delivered (optional) 2. Outsourced Transcription ● Name of supplier & product ● Procurement method (e.g., framework) ● Contract start date ● Average monthly volume of letters (if available) ● Average monthly volume of lines (if available) ● Total contract value (if available) ● Key internal stakeholder role/title ● Desired features not currently delivered (optional) 3. Speech Recognition ● Name of supplier & product ● Number of user licences ● Procurement method (e.g., framework) ● Contract start date ● Contract expiry date (please specify fixed end date vs option to extend/rolling contract) ● Total contract value (if available) ● Integration with PAS/EPR (please specify if outbound only – e.g., patient demographics, clinic work list – or outbound and inbound, e.g., document return) ● Key internal stakeholder role/title ● Desired features not currently delivered (optional) 4. Ambient AI Scribe ● Name of supplier & product ● Number of user licences ● Procurement method (e.g., framework) ● Contract start date ● Contract expiry date (please specify fixed end date vs option to extend/rolling contract) ● Total contract value (if available) ● Integration with PAS/EPR (please specify if outbound only – e.g., patient demographics, clinic work list – or outbound and inbound, e.g., document return) ● Pilot stage (if applicable, please specify supplier, pilot duration, and scope) ● Key internal stakeholder role/title ● Desired features not currently delivered (optional) 5. Video Consultation ● Name of supplier & product ● Number of user licences ● Procurement method (e.g., framework) ● Contract start date ● Contract expiry date (please specify fixed end date vs option to extend/rolling contract) ● Total contract value (if available) ● Integration with PAS/EPR (please specify if outbound only – e.g., patient demographics, clinic work list – or outbound and inbound, e.g., document return) ● Key internal stakeholder role/title ● Desired features not currently delivered (optional) ● Average number of video appointments per month/year ● % of virtual/remote consultations conducted using video vs telephone 6. Health Information Systems Name of supplier & product of the following HIS: ● PAS (Patient Administration System) ● EPR (Electronic Patient Record) ● eDMS (Electronic Document Management System) ● RIS (Radiology Information System) ● LIMS (Laboratory Information Management System) ● e-Correspondence (e.g. Docman) ● Hybrid Mail (e.g. Synertec, Healthcare Communications) ● Patient Portal (e.g. Patient Knows Best)
Date of Response: 05/03/2026
View Response: 11040.pdf
Freedom of Information Request Reference: 11020
Date Received: 09/01/2026
Summary:
I would like to request the following information regarding inbound telephone activity into your Outpatient Booking/Appointment Teams. 1. Total inbound calls received by your Outpatient Booking/Appointment Teams (most recent 12-month period of available data. ) 2. Percentage of abandoned calls 3. Average call answer time (ASA) 4. Categories/reasons for inbound calls received
Date of Response: 18/02/2026
View Response: 11020.pdf
Freedom of Information Request Reference: 11018
Date Received: 08/01/2026
Summary:
Under the Freedom of Information (Scotland) Act 2002, I request the following information regarding the Lothian Sleep Service: Service Activity and Waiting Times (a) The total number of face-to-face (or zoom) patient appointments conducted by each consultant within the Lothian Sleep Service for each of the past three financial years (2022/23, 2023/24, 2024/25 to date), broken down by individual consultant. (b) The average waiting time from referral to first appointment for patients referred to the Lothian Sleep Service for each of the past three financial years. (c) The average waiting time from first appointment to follow-up appointment for patients within the Lothian Sleep Service for each of the past three financial years. (d) The number of patients currently on the waiting list for the Lothian Sleep Service, and the longest current wait time. A segregation by patient area eg (Borders and Lothian patients and any other areas serviced) (e) The number of patient appointments cancelled by the service (as distinct from patient-initiated cancellations) for each of the past three financial years. Workforce Capacity and Deployment (f) The staffing establishment for the Lothian Sleep Service (consultant, nursing, administrative) compared to actual staffing levels (whole-time equivalents) for each of the past three financial years. (g) The number of programmed activities (PAs) or sessions allocated to the Lothian Sleep Service by each consultant, and the proportion of those PAs dedicated to direct clinical care versus other activities. How much time is worked offsite? (h) Any workforce planning documents, capacity assessments, or job plans relevant to the Lothian Sleep Service produced in the past three years. (i) Details of any vacancies within the Lothian Sleep Service and the duration for which posts have remained unfilled. Efficiency and Performance Metrics (j) Any efficiency metrics, key performance indicators (KPIs), or productivity measures used to assess the performance of the Lothian Sleep Service. (k) The DNA (did not attend) rate for the Lothian Sleep Service for each of the past three financial years. (l) The average number of patients seen per clinic session within the Lothian Sleep Service. (m) Any benchmarking data comparing the Lothian Sleep Service's performance against other NHS Scotland sleep services or national standards. Service Improvement and Reviews (n) Details of any measures implemented to reduce waiting times within the Lothian Sleep Service over the past three years, including any business cases submitted for additional resources. (o) Any internal reports, audits, service reviews, or quality improvement initiatives conducted regarding the performance or capacity of the Lothian Sleep Service over the past three years.
Date of Response: 05/03/2026
View Response: 11018.pdf
Freedom of Information Request Reference: 11015
Date Received: 08/01/2026
Summary:
Question - In NHS Lothian, can a GP prescribe pregabalin and or gabapentin for treatment of restless leg syndrome? Question – in NHS Lothian what the treatment pathway for the treatment of restless leg syndrome? Question – What are the current waiting times for a first outpatient appointment for neurology, from referral to first outpatient appointment?
Date of Response: 05/03/2026
View Response: 11015.pdf
Freedom of Information Request Reference: 10995
Date Received: 05/01/2026
Summary:
Please provide the following information relating to employee exposure to formaldehyde (formalin) in the Trust’s operating/surgical theatres. Documents requested: 1. Please provide the current COSHH risk assessment(s) relating to formaldehyde (formalin) exposure for staff working in operating/surgical theatres, produced to meet the Trust’s duties under COSHH Regulation 6. 2. Please provide copies of all formaldehyde (formalin) exposure monitoring data held by the Trust for operating/surgical theatre staff for the last 12 months, including: o Fixed/static air monitoring results o Personal exposure or badge monitoring results (with personal data redacted as appropriate) This request includes monitoring undertaken for any purpose, including baseline, verification, and/or investigation monitoring, in line with COSHH Regulation 10. It is noted that COSHH Regulation 10(5)(b) requires such records to be kept for a minimum of five years. Questions: 3. How does the Trust prevent or control employee exposure to formaldehyde (formalin) in its operating/surgical theatres, including but not limited to engineering, procedural, and/or organisational controls? 4. Does the Trust undertake regular scheduled formaldehyde (formalin) exposure monitoring in operating/surgical theatres? If so, please state the frequency. 5. Please state the total number of occasions on which regular scheduled formaldehyde (formalin) exposure monitoring has been undertaken in operating/surgical theatres in the last 12 months. 6. If regular scheduled formaldehyde (formalin) exposure monitoring is not undertaken, please provide documentation held by the Trust that demonstrates the effectiveness of current controls and supports the decision that routine monitoring is not required. If no such documentation is held, please confirm how the Trust assures compliance with COSHH Regulations 7 and 10 in the absence of routine exposure monitoring.
Date of Response: 18/02/2026
View Response: 10995.pdf
Freedom of Information Request Reference: 10977
Date Received: 22/12/2025
Summary:
Please provide the formaldehyde exposure risk assessment that is currently used by the Trust’s gastrointestinal endoscopy team to fulfill employer obligations under COSHH regulations (2002) Section 6. Please provide all formaldehyde exposure monitoring data (both fixed static monitoring and personal badge monitoring, with personal details redacted as appropriate) relating to the Trust’s gastrointestinal endoscopy service encompassing the last 12 months that is used to fulfill employer obligations under COSHH regulations (2002) Section 10. It is noted that such records should be kept available for at least 5 years under COSHH regulations (2002) Section 10(5)(b). Questions: How often is regular scheduled formaldehyde exposure monitoring undertaken in the Trust’s gastrointestinal endoscopy suite? What is the total number of occasions formaldehyde regular scheduled exposure monitoring has been undertaken in the Trust’s gastrointestinal endoscopy suites over the last 12 months?
Date of Response: 23/02/2026
View Response: 10977.pdf
Freedom of Information Request Reference: 10975
Date Received: 22/12/2025
Summary:
I wish to request the following information held by NHS Lothian under the Freedom of Information (Scotland) Act 2002. 1. Copies of all email correspondence sent by, or on behalf of, the Chief Executive of NHS Lothian to officials within the Scottish Government that relates to subnational planning. This should include references to planning governance, proposed models, implications for regional services, and any discussion touching upon workforce planning, recruitment to planning related posts, responsibility allowances for senior roles, or remuneration associated with planning functions. I request that this covers the period from 1 January 2022 to the date of this request and should include attachments or briefing material. 2. Copies of email correspondence between the Chief Executive of NHS Lothian and the Chief Executive of NHS Greater Glasgow and Clyde concerning subnational planning. This should include discussion involving shared regional planning approaches, communications about staffing or recruitment to planning roles, allocation of responsibility allowances, or consideration of trade union engagement. The same time period applies and should include attachments and forwarded content held by NHS Lothian. 3. Copies of agendas, notes, minutes, papers, and action logs for any meetings attended or convened by the Chief Executive of NHS Lothian where subnational planning was discussed. This should also include meetings where recruitment to planning roles, adjustments to responsibility allowances, or trade union dialogue relating to subnational planning were considered. Please provide the date and title of each identified meeting and supply any associated agenda or papers held. 4. A list of meetings attended by the Chief Executive of NHS Lothian with the First Minister or Scottish Government ministers where subnational planning, regional planning, workforce or recruitment matters, responsibility allowances, or trade union dialogue were discussed. For each meeting identified, please provide the date, attendees, and any agenda or supporting documents that NHS Lothian holds. 5. Any correspondence held by NHS Lothian that records trade union dialogue, representations, or consultation relating to subnational planning, including any matters connected to staffing, recruitment, responsibility allowances, or consequential workforce changes.
Date of Response: 02/02/2026
View Response: 10975.pdf
Freedom of Information Request Reference: 10986
Date Received: 29/12/2025
Summary:
I would be grateful if you could provide the following: 1. In the past 10 years, how many individuals assigned male at birth and identifying as female have received NHS-funded facial hair removal (including, but not limited to, electrolysis and laser treatment) within your health board, as part of gender identity/gender-affirming care? 2. In the past 10 years, how many individuals assigned male at birth and identifying as male have received NHS funded facial hair removal (including, but not limited to, electrolysis and laser treatment) within your health board? 3. In the past 10 years, how many individuals assigned female at birth have received NHS-funded facial hair removal for reasons other than cancer or reconstructive surgery – including, but not limited to, cases related to hirsutism, PCOS, mental health or emotional/psychological distress? If available, please provide a breakdown by year, and indicate whether treatment was delivered in-house or commissioned externally. Additionally, please provide copies of your board’s policies, guidelines and clinical criteria currently in use for assessing eligibility for NHS-funded hair removal for both: • Individuals receiving gender identity/gender dysphoria treatment • Individuals with dermatological, endocrine, or aesthetic concerns
Date of Response: 24/02/2026
View Response: 10986.pdf
Freedom of Information Request Reference: 11061
Date Received: 16/01/2026
Summary:
Question 1. How many patients have a current diagnosis for Spinal Muscular Atrophy (ICD-10 Code G12.0, G12.1, G12.8 and G12.9) at your trust? Question 2. How many patients have been treated in the last 4 months (September to December 2025) with the following products: • Evrysdi (Risdiplam) - total patients • Spinraza (Nusinersen) - total patients • Zolgensma (Onasemnogene) - total patients • Evrysdi (Risdiplam) – new* patients • Spinraza (Nusinersen) – new* patients • Zolgensma (Onasemnogene) – new* patients
Date of Response: 13/02/2026
View Response: 11061.pdf
Freedom of Information Request Reference: 11059
Date Received: 16/01/2026
Summary:
Please can you inform me if your Health Board is currently or intends to work with the private company Flatiron Health UK in the future. If you are can you detail the length of the contract and the extent to which patient data including CHIs are being sent to this company.
Date of Response: 11/02/2026
View Response: 11059.pdf
Freedom of Information Request Reference: 11058
Date Received: 15/01/2026
Summary:
Can you please provide the Current Market Rent for GP surgeries within the Edinburgh city boundary for the last 24 months." is possible I would like the following surgeries annual rent and £X per square meter if possible • Blackhall Edinburgh • Murrayfield medical practice Edinburgh • Stockbridge heath centre Edinburgh • Leven medical practice • Gilmore medical practice
Date of Response: 12/02/2026
View Response: 11058.pdf
Freedom of Information Request Reference: 11057
Date Received: 15/01/2026
Summary:
1) How many international hires, with a breakdown by country and job role (junior doctor, nurse etc.) have been recruited from 'red list' countries during each of the following financial years: - o 2019/20 o 2020/21 o 2021/22 o 2022/23 o 2023/24 o 2024/25 o 2025/26 (most recent) 2) How many international hires from 'red list' countries are still employed by your health board, again broken down by country and job role?
Date of Response: 11/02/2026
View Response: 11057.pdf
Freedom of Information Request Reference: 11056
Date Received: 16/01/2026
Summary:
NHS WAITING TIMES 1)For the year 2025, pls outline how many patients who were on waiting lists, had their 'clocks' reset. 2) Out of the total, pls specify the reasons for the clocks being reset ie how many were Did Not Attend and how many were Could Not Attend. 3) Pls also outline how many patients were removed from a waiting list altogether and what the clinical reason was for their removal. For the above three questions pls provide answers for the years, 2021, 2022, 2023 and 2024 as well.
Date of Response: 13/02/2026
View Response: 11056.pdf
Freedom of Information Request Reference: 11054
Date Received: 15/01/2026
Summary:
To ask how many patients have been admitted to hospital in your area following assault by a sharp object in the following years... 2025 2024 2023 2022 2021 Could this information be broken down by year.
Date of Response: 12/02/2026
View Response: 11054.pdf
Freedom of Information Request Reference: 11053
Date Received: 15/01/2026
Summary:
I am writing to request recorded information under the Freedom of Information (Scotland) Act 2002 relating to work-related asthma potentially linked to salmon or seafood processing. I appreciate that “salmon processing” may not exist as a discrete category. Where it does not, please use the closest available proxy such as fish processing or seafood processing recorded as an occupation or industry, and any available exposure notes. Time period Please cover calendar years 2015 to 2025 inclusive. 1. Work-related asthma counts Please provide annual anonymised counts of patients where occupational asthma or work-related asthma is recorded (or the closest equivalent code/flag used by the Board), and where occupation or industry is recorded as fish processing, seafood processing, or salmon processing (or closest available). If held, please provide the counts split by: a) year b) the patient’s NHS Board area (if different to this Board) or by locality within the Board if that is how it is recorded. 2. Recorded trigger or suspected agent If your systems record suspected trigger or causative agent for asthma, please provide annual anonymised counts where the trigger/agent is recorded as fish or seafood proteins, fish processing, seafood aerosols, or similar terms used locally. 3. Clinic pathway signal If held, please provide annual counts of referrals to respiratory clinics or occupational medicine services where the referral is flagged as work-related asthma or occupational asthma and the occupation/industry is fish or seafood processing (as above). 4. Recording practice Please confirm whether your systems include standard fields for: a) occupation or industry, and b) suspected occupational trigger or causative agent, for asthma referrals or respiratory clinic episodes, and if so what categories are available that relate to fish or seafood processing.
Date of Response: 10/02/2026
View Response: 11053.pdf
Freedom of Information Request Reference: 11051
Date Received: 15/01/2026
Summary:
Please advise what national or international guideline were used by the Chalmers Gender Identity Service to produce prescribing guidance for GPs e.g. shared care agreements, directed/ local enhanced services or prescribing guidelines. This includes advice given to GPs on prescribing oestrogen or testosterone (drug preparations and dose titration), blood monitoring and monitoring for adverse effects.
Date of Response: 12/02/2026
View Response: 11051.pdf
Freedom of Information Request Reference: 11050
Date Received: 14/01/2026
Summary:
The amount of births overall in NHS Lothian in 2025 The amount of homebirths completed at home in NHS Lothian in 2025
Date of Response: 10/02/2026
View Response: 11050.pdf
Freedom of Information Request Reference: 11047
Date Received: 14/01/2026
Summary:
1. The total number of NHS dental patients registered with a NHS dentist under the board. 2. The total number of patients believed to living under the board but not registered with an NHS dental practice. 3. The number of NHS dental patients who have not had a dental appointment in the last (i) 12 months (ii) 24 months (iii) 36 months (iiii) 48 months (iiii) 5 Years or more For each figure above, please, if possible, reveal what they are in terms of the % of the overall amount of patients under the board. So for example state how many patients haven't had an appointment in 12 months and how many people that is within the overall number of patients under the board.
Date of Response: 11/02/2026
View Response: 11047.pdf
Freedom of Information Request Reference: 11046
Date Received: 14/01/2026
Summary:
1. Confirmation of whether or not board receives an annual report of sorts regarding NHS dentistry. In other words, a report or body of analysis that provides an overview of a year in terms of dental treatment, patient dental health and figures regarding treatment. 2. If so please provide a copy of that annual report/analysis for the last five years. Please note I am referring to document/briefing material which informs the board about the specific details of dental treatment of the board, such as how many patients were treated, emerging trends, potential issues etc. 3. Please provide the latest document or analysis specifically regarding tooth decay.
Date of Response: 11/02/2026
View Response: 11046.pdf
Freedom of Information Request Reference: 11045
Date Received: 14/01/2026
Summary:
Q1. How many patients were treated by the rheumatology department in the past 3 months with the following: •Tocilizumab – for any disease •Tocilizumab for rheumatoid arthritis (RA) only •Tocilizumab for giant cell arteritis (GCA) only Q2. How many patients were treated by the ophthalmology department (for any disease) in the past 3 months with Tocilizumab? Q3. How many patients were treated in A&E in the past 3 months for giant cell arteritis (GCA) with Tocilizumab? Q4. In the past 3 months, how many patients with a primary diagnosis of GCA (ICD10 codes M31.5 or M31.6) were: •Admitted as an inpatient •Treated in A&E
Date of Response: 10/02/2026
View Response: 11045.pdf
Freedom of Information Request Reference: 11044
Date Received: 14/01/2026
Summary:
1. A list of all reasons recognised by the health board for a dental patient to become deregistered. 2. The number of dental Patients who are recognised as having been deregistered as NHS patients in the last seven years (2019, 2020, 2021, 2022, 2023, 2024 and 2025) Please provide a breakdown of the number of deregistered patients per year and by reason for deregistration.
Date of Response: 09/02/2026
View Response: 11044.pdf
Freedom of Information Request Reference: 11043
Date Received: 14/01/2026
Summary:
FOI Request: Acute Myeloid Leukaemia (AML) Patients 1. How many patients have been diagnosed with Acute Myeloid Leukaemia (AML) at your Trust in the last 12 months a. Of these patients how many are refractory/relapsed (R/R)? b. How many of the R/R patients were FLT3 positive? 2. How many patients have been treated for AML in the latest 12 months with the following treatments • Venetoclax with azacitidine • Midostaurin • Quizartinib • Gemtuzumab • Ivosidenib with azacitidine • Liposomal cytarabine–daunorubicin • Oral azacitidine • Gilteritinib • Palliative care • Enrolled in a clinical trial 3. How many relapsed/refractory patients have been treated for AML in the last 12 months with the following treatments (This question relates to treatments administered to relapsed/refractory AML patients in clinical practice, regardless of licence status or funding route (including any off-label use). • Venetoclax with azacitidine • Midostaurin • Quizartinib • Gemtuzumab • Ivosidenib with azacitidine • Liposomal cytarabine–daunorubicin • Oral azacitidine • Gilteritinib • Palliative care • Enrolled in a clinical trial 4. Of your AML patient how many were tested as below in the last 12 months • Received an FLT3 mutation test when they were diagnosed • Received an FLT3 mutation test when their disease relapsed • Received an FLT3 mutation test when their disease became refractory
Date of Response: 11/02/2026
View Response: 11043.pdf
Freedom of Information Request Reference: 11042
Date Received: 13/01/2026
Summary:
For each of the last five completed financial years for which information is held, please provide: 1. The total annual sums paid by or attributable to this NHS health board in respect of maternity/obstetric clinical negligence claims, including: o Compensation or damages paid to pursuers o Defender legal costs paid by or on behalf of the Board 2. The number of maternity/obstetric clinical negligence claims: o Newly intimated during each financial year o Settled during each financial year (whether with or without admission of liability) 3. Where applicable, confirmation of whether claims or payments are: o Recorded locally by this NHS health board, or o Managed centrally (for example by the Central Legal Office), but with figures attributable to the Board.
Date of Response: 06/02/2026
View Response: 11042.pdf
Freedom of Information Request Reference: 11041
Date Received: 14/01/2026
Summary:
1. How many students applied to the Nursing and Midwifery return to practice course from your health board area for the following academic years: 2018, 2019, 2020, 2021, 2022, 2023, 2024 2. How many students met the minimum specified qualifications within application for the Nursing and Midwifery return to practice course from your health board area for the following academic years: 2018, 2019, 2020, 2021, 2022, 2023, 2024 3. The average, mean, and most number of attempts required by individuals to receive a place on the Nursing and Midwifery return to practice course from your health board area for the following academic years: 2018, 2019, 2020, 2021, 2022, 2023, 2024
Date of Response: 11/02/2026
View Response: 11041.pdf
Freedom of Information Request Reference: 11039
Date Received: 14/01/2026
Summary:
I would be grateful if you could instead provide all information and documentation held by NHS Lothian showing or tending to show: 1. The average waiting time for a patient to be seen by NHS Lothian’s Ophthalmology Department, following a routine referral from any referrer. 2. The average waiting time for a patient to be seen by NHS Lothian’s Ophthalmology Department, following a routine referral from a referrer who was not a GP in December 2020.
Date of Response: 11/02/2026
View Response: 11039.pdf
Freedom of Information Request Reference: 11038
Date Received: 14/01/2026
Summary:
In the last 3 months (October, November, December 2025), how many haemophilia A and B and von Willebrand patients were treated with the following coagulation factors in your trust and how much volume (IUs or mg) was used? Hemlibra (non-inhibitor patients) Hemgenix Altuvoct Advate Adynovi Elocta Esperoct NovoEight ReFacto AF Nuwiq Hympavzi Idelvion Refixia Alprolix BeneFIX Replenine Rixubis Veyvondi Voncento Wilate Willfact
Date of Response: 11/02/2026
View Response: 11038.pdf
Freedom of Information Request Reference: 11037
Date Received: 12/01/2026
Summary:
Q1. How many patients who have a current diagnosis of Multiple Sclerosis received treatment in the last six months with any of the following treatment regimens (July 2025 – December 2025)? • Ocrevus (ocrelizumab) IV (300mg/30ml) • Ocrevus (ocrelizumab) Subcutaneous (920mg/23ml) • Kesimpta (ofatumumab) • Briumvi (ublituximab) • Mavenclad (cladribine) • Dimethyl Fumarate (Tecfidera + Dimethyl Fumarate generic) • Natalizumab (Tysabri and Tyruko) Q1a. Of the patients identified in question one, how many patients received the same treatment in the previous six-month period? (i.e. How many of the same patients received treatment with each treatment regimen in January 2025 to June 2025 AND July 2025 – December 2025?) • Ocrevus (ocrelizumab) IV (300mg/30ml) • Ocrevus (ocrelizumab) Subcutaneous (920mg/23ml) • Kesimpta (ofatumumab) • Briumvi (ublituximab) • Mavenclad (cladribine) • Dimethyl Fumarate (Tecfidera + Dimethyl Fumarate generic) • Natalizumab (Tysabri and Tyruko) Q2. How many patients have received a new diagnosis for Multiple Sclerosis in the latest six-month period (July 2025 – December 2025)? Q2a. Of the patients identified in question two, how many of these patients have received any of the following treatment regimens as their first treatment following their Multiple Sclerosis diagnosis? • Ocrevus (ocrelizumab) IV (300mg/30ml) • Ocrevus (ocrelizumab) Subcutaneous (920mg/23ml) • Kesimpta (ofatumumab) • Briumvi (ublituximab) • Mavenclad (cladribine) • Dimethyl Fumarate (Tecfidera + Dimethyl Fumarate generic) • Natalizumab (Tysabri and Tyruko)
Date of Response: 06/02/2026
View Response: 11037.pdf
Freedom of Information Request Reference: 11036
Date Received: 13/01/2026
Summary:
Q1. In the last 6 months, how many patients have been diagnosed with Diffuse Large B Cell Lymphoma (DLBCL)? Q1a. Of these patients, how many commenced treatment at your trust within the last 6 months? Q2. In the last 6 months, how many patients have you treated for Diffuse Large B Cell Lymphoma (DLBCL) with the following treatments: • R-CHOP (rituximab, cyclophosphamide, doxorubicin hydrochloride, vincristine and prednisolone) • R-mini-CHOP (rituximab, cyclophosphamide, doxorubicin hydrochloride, vincristine and prednisolone) • Pola-BR (polatuzumab vedotin with rituximab and bendamustine) • Pola-R-CHP (Polatuzumab vedotin with rituximab, cyclophosphamide, doxorubicin hydrochloride, and prednisolone) • R-CODOX-M (rituximab, cyclophosphamide, vincristine, doxorubicin and methotrexate) • R-IVAC (rituximab, ifosfamide, etoposide and cytarabine) • R-GCVP (Rituximab, gemcitabine, cyclophosphamide, vincristine, prednisolone) • (DA)-EPOCH +/-R (Prednisolone, doxorubicin, vincristine, etoposide, cyclophosphamide, rituximab) • R-GemOX (rituximab, gemcitabine and oxaliplatin) • Axicabtagene ciloleucel • Tisagenlecleucel • Epcoritamab • Loncastuximab tesirine • Glofitamab • Any other SACT • Stem cell transplant or bone marrow transplant (autologous or allogeneic) Q3. In the last 6 months, how many patients have received the following 2nd line treatments for Diffuse Large B Cell Lymphoma (DLBCL): • Axicabtagene ciloleucel (Yescarta) • Tisagenlecleucel • Pola-BR (polatuzumab vedotin with rituximab and bendamustine) • R-GemOX (rituximab, gemcitabine and oxaliplatin) • Stem cell transplant or bone marrow transplant (autologous or allogeneic) • Glofitamab • Any other treatments Q4. In the last 6 months, how many patients has the Trust treated for 3rd line Diffuse Large B Cell Lymphoma (BLBCL)? Q5. In the last 6 months, how many patients have you referred to other trusts for the treatment of Diffuse Large B Cell Lymphoma (DLBCL) for the following treatments: • CAR-T Therapy (E.g. Axicabtagene ciloleucel) • Stem cell transplant or bone marrow transplant (autologous or allogeneic) • Any other treatment
Date of Response: 10/02/2026
View Response: 11036.pdf
Freedom of Information Request Reference: 11035
Date Received: 13/01/2026
Summary:
Can you please advise the average waiting time for a person for a MRI back scan when the person has been referred for the scan from the "NHS Lothian Department of Spinal iMSK Advanced Practice" (from referral date to the date of the appointment for the MRI scan)? This would be for a person is on the normal waiting list and not the urgent waiting list for a MRI back scan.
Date of Response: 10/02/2026
View Response: 11035.pdf
Freedom of Information Request Reference: 11034
Date Received: 13/01/2026
Summary:
AI system information 1. How many artificial intelligence (AI) systems does your trust/health board currently have in development and what is the name of the AI system? 2. How many AI systems are currently deployed within your trust/health board and what is the name of the AI system? 3. For every AI model currently being used or developed in your trust: 3a. Is the AI model being used operationally, clinically, or for another purpose? 3b. What department(s) is the AI system being used in? 3c. What month and year was the AI system first deployed? (n/a if in development). 3d. Was the AI system created by a commercial entity, university, in-house, or within another NHS trust? Please give the name of the organisation. 3e. What is the AI systems architecture? (e.g. deep neural network, random forest, logistic regression, large language model). 3f. Which coding language and packages are used to deploy the AI system? (e.g. python - scikit-learn, pytorch, tensorflow) 3g. What is the nature of the input of the AI system? (e.g. a medical scan, free text notes, tables of lab results). 3h. What is the nature of the output of the AI system? (e.g. a masked image, a risk score, natural text). 3i. How was the AI system validated in the target population before deployment? 3j. What measures are in place to monitor for degradation in the performance of the AI system post-deployment? 3k. What was the cost to procure the AI model and what is the ongoing cost of use? 3l. Which departmental budget is the cost paid from? Data management 4. Was any local patient data used for training or fine tuning the AI system? 5. Is any patient data collected specifically for the purpose of training any of the AI systems currently in development or deployment? 6. Do you share, or plan to share, any patient data with third-party developers for AI-related purposes? If yes, please provide details of the data-sharing agreement or relevant policy. Regulation 7. What is the regulation and certification of the AI model under the European Union Medical Device Directive and/or United Kingdom Medicines and Healthcare products Regulatory Agency (MHRA)? Patient/public involvement 8. Was any patient/public engagement undertaken before deployment of the AI system? 9. Is there any ongoing patient/public engagement input into the use of AI within your organisation? Governance 10. Who has responsibility for the AI systems being using? 11. Does your organisation have a governance policy that covers: 11a. Use of AI systems within your organisation? 11b. Ongoing evaluation of an AI model's performance after deployment? 11c. How to monitor for bias in the AI system and how to mitigate against this?
Date of Response: 13/02/2026
View Response: 11034.pdf
Freedom of Information Request Reference: 11033
Date Received: 12/01/2026
Summary:
If NHS Lothian will be reinstating and expanding their contract with GJH for knee surgery?
Date of Response: 09/02/2026
View Response: 11033.pdf
Freedom of Information Request Reference: 11032
Date Received: 13/01/2026
Summary:
As a research project for a cyber EPQ, I am seeking information relating to Business continuity plans (BCPs). 1. Does NHS Lothian have a BCP? 2. When was it last updated? 3. Does it include cyber-specific scenarios? 4. Have you conducted any cyber incident exercises? 5. Are the documented BCPs updated after major incidents, is there a lessons learnt process?
Date of Response: 10/02/2026
View Response: 11032.pdf
Freedom of Information Request Reference: 11031
Date Received: 13/01/2026
Summary:
Question 1. How many patients with HIV in total were seen for care and treated with ART in your Trust in the latest 3 months of available data? ______ total patients treated with ART Question 2. How many patients newly diagnosed with HIV were initiated on Antiretroviral Therapy (ART) in your Trust in the latest 3 months of available data? _____ total patients newly diagnosed initiated on ART Question 3. How many patients with HIV have had their ART switched in your Trust in the latest 3 months of available data? _____ patients who switched therapy Question 4. Of the patients identified in Question 3, how many were switched from/to the following therapies? Emtricitabine/tenofovir alafenamide (fixed dose combination) + any other ART to Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) Emtricitabine/tenofovir alafenamide (fixed dose combination) + any other ART to Dovato (dolutegravir/lamivudine) Emtricitabine/tenofovir disoproxil (fixed dose combination) + any other ART to Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) Emtricitabine/tenofovir disoproxil (fixed dose combination) + any other ART to Dovato (dolutegravir/lamivudine) Triumeq (dolutegravir/abacavir/lamivudine) to Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) Triumeq (dolutegravir/abacavir/lamivudine) to Dovato (dolutegravir/lamivudine) Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) to Dovato (dolutegravir/lamivudine) Any other ART** to Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) Any other ART** to Dovato (dolutegravir/lamivudine) Question 5. Please specify the dates of the latest 3 months of available date in month / year format.
Date of Response: 10/02/2026
View Response: 11031.pdf
Freedom of Information Request Reference: 11030
Date Received: 12/01/2026
Summary:
MENTAL HEALTH — CAHHS REFERRALS AND WAITS For the year, 2025: 1) Pls outline the median wait (in days) between the initial meeting (assessment/choice appointment), where a CAMHS professional will talk to a patient and decide on how to help them to the start of treatment. 2) Pls also outline the longest wait (in days) between the initial meeting (assessment/choice appointment) and the start of treatment. 3) Pls supply the above answers for the years, 2023 and 2024. Also: 4) As of January 12, 2026, please outline the number of vacancies in your health board in the following positions: 1. Psychologist 2. Neuropsychologist 3. consultant psychiatrist 4. Psychotherapist 5. Education Mental Health Practitioners (EMHPs) 6. Children's Wellbeing Practitioners (CWPs)
Date of Response: 12/02/2026
View Response: 11030.pdf
Freedom of Information Request Reference: 11028
Date Received: 12/01/2026
Summary:
1. How many people were removed from an outpatient/inpatient waiting list in the calendar year 2025 for a reason other than having had the appointment, or death. Please provide the reasons for this removal in each case. For example, X were removed due to leaving the area. 2. Whether it is the case that people are removed from waiting lists if they do not confirm their intention to remain on it within 21 days in response to a letter sent to them checking this. If this is the case, how many were removed for this reason in 2025?
Date of Response: 09/02/2026
View Response: 11028.pdf
Freedom of Information Request Reference: 11027
Date Received: 09/01/2026
Summary:
• The number of incidents of bullying and harassment (excluding sexual misconduct) reported each year for the last five years • A breakdown of incidents of bullying and harassment by medical specialty including anaesthetists • The number of incidents of sexual misconduct reported each year for the last five years. • A breakdown of incidents of sexual misconduct by medical specialty including anaesthetists • The number of staff dismissed as a result of each of these incidents.
Date of Response: 06/02/2026
View Response: 11027.pdf
Freedom of Information Request Reference: 11026
Date Received: 09/01/2026
Summary:
• How many doctors are on a SAS contract, broken down by medical specialty? • How many are doctors are on specialist doctor contracts, broken down by medical specialty? • How many doctors are on specialty doctor contracts, broken down by medical specialty? • How many doctors are on associate specialists, broken down by medical specialty? • How many doctors are on a staff grade contract, broken down by medical specialty? • How many doctors are employed in the Trust that are not in a formal training programme or on a SAS or consultant contract, broken down by medical specialty?
Date of Response: 02/02/2026
View Response: 11026.pdf
Freedom of Information Request Reference: 11025
Date Received: 12/01/2026
Summary:
Please could you provide the following details regarding your Trust’s use of digital systems in the endoscopy, respiratory and urology department: 1. Does your Trust currently use any software systems to manage clinical records, diagnostics, or workflows within endoscopy, cytoscopy and bronchoscopy? 2. If yes, please provide: o The name of the software provider and product. o The start date and duration of the current contract. o The expiry date or next renewal date of the contract. o Whether the contract includes options for extension or renewal.
Date of Response: 10/02/2026
View Response: 11025.pdf
Freedom of Information Request Reference: 11024
Date Received: 09/01/2026
Summary:
Can a patient's assessment for a neurodevelopmental condition be expedited for an assessment if there is a serious comorbid mental health illness/issue and what would be the process within NHS Lothian specifically in the west Lothian area for this to be expedited.
Date of Response: 03/02/2026
View Response: 11024.pdf
Freedom of Information Request Reference: 11023
Date Received: 12/01/2026
Summary:
From 1st October 2025 to 31st December please provide a breakdown of: • Total trust spend with framework agencies for locum AHP/HSS staffing. Please provide a further breakdown for locum AHP/HSS staffing by: • Spend per band • Spend per specialty • Spend per agency name In the period 1st October 2025 to 31st December please provide a breakdown of: • Total trust spend with off-framework agencies for locum AHP/HSS staffing. Please provide a further breakdown for locum AHP/HSS staffing by: • Spend per band • Spend per specialty • Spend per agency name In the period 1st October 2025 to 31st December please provide a breakdown of: • Total trust spend with the internal trust bank or associated external provider for locum AHP/HSS staffing Please provide a further breakdown for locum AHP/HSS staffing by: • Spend per grade • Spend per specialty • Spend per internal or associated external provider Please confirm your allocated budget for agency locum AHP/HSS staffing for the period 1st October 2025 to 31st December Please confirm the framework you utilise for AHP/HSS agency staff.
Date of Response: 06/02/2026
View Response: 11023.pdf
Freedom of Information Request Reference: 11021
Date Received: 12/01/2026
Summary:
1. Whether cold debriefs are routinely conducted following critical events 2. The specified timeframe for when cold debriefs are held following an event 3. Which staff groups or roles are expected or required to attend cold debriefs, including nonparticipants of the critical event 4. Which role, team, or department is responsible for organising and facilitating cold debriefs 5. Whether a standard pro forma, template, or guidance document is used for cold debriefs, and if so, a copy of the most recent version.
Date of Response: 09/02/2026
View Response: 11021.pdf
Freedom of Information Request Reference: 11019
Date Received: 09/01/2026
Summary:
1. How many of the following intra-vitreal injections/implants has your trust administered in the four-month period from September to December 2025: • Aflibercept • Bevacizumab • Brolucizumab • Dexamethasone • Faricimab • Fluocinolone acetonide • Ranibizumab - Lucentis • Ranibizumab - Biosimilar 2. Please provide the number of injections/implants administered within the four-month period from September to December 2025 with the below treatments for noninfectious Uveitis (NIU) only • Dexamethasone • Fluocinolone acetonide
Date of Response: 30/01/2026
View Response: 11019.pdf
Freedom of Information Request Reference: 11017
Date Received: 08/01/2026
Summary:
Please could I request the following information: • Agency locum spend between August 2025 to present • Breakdown of speciality and grade this spend was used in • The breakdown between direct engagement and non direct engagement this spend was used in • If any non direct engagement spend, what speciality and grade was this used in • Any off framework spend? If so please include speciality and grade. • A list of all service or general managers at the trust including the department they cover
Date of Response: 05/02/2026
View Response: 11017.pdf
Freedom of Information Request Reference: 11016
Date Received: 08/01/2026
Summary:
From January 2025 to 31st December 2025 please provide a breakdown month by month of total trust spend for framework agency staff within NON medical NON clinical, please break it down by: • Total spend • Spend per area EG – Admin and Clerical: Includes roles like receptionists, medical secretaries, ward clerks, administrators, and HR staff. Estates and Facilities: Encompasses porters, cleaners, caterers, maintenance workers, security staff, and drivers. Scientific, Therapeutic, and Technical Staff: A diverse group including various professions that do not fall under the direct 'medical' or 'nursing' umbrella. Corporate Services: Includes areas such as IT, finance, legal, and clinical coding. • Spend per agency EG- Total £10,000 Facilities £5,000 Admin £5,000 Agency x £5,000 facilities £5,000 Admin From January 2025 to 31st December 2025 please provide a breakdown month by month of total trust spend for off-framework agency staff within NON medical NON clinical, please break it down by: • Total spend • Spend per area EG – Admin and Clerical: Includes roles like receptionists, medical secretaries, ward clerks, administrators, and HR staff. Estates and Facilities: Encompasses porters, cleaners, caterers, maintenance workers, security staff, and drivers. Scientific, Therapeutic, and Technical Staff: A diverse group including various professions that do not fall under the direct 'medical' or 'nursing' umbrella. Corporate Services: Includes areas such as IT, finance, legal, and clinical coding. • Spend per agency EG- Total £10,000 Facilities £5,000 Admin £5,000 Agency x £5,000 facilities £5,000 Admin From January 2025 to 31st December 2025, please confirm which framework was used for the recruitment of agency staff within NON Medical NON clinical Please confirm whether the trust utilises a 3rd party vendor or tech system for the hiring of the NON Medical NON Clinical agency staff. If so, please confirm the name of the vendor / tech provider:
Date of Response: 29/01/2026
View Response: 11016.pdf
Freedom of Information Request Reference: 11014
Date Received: 08/01/2026
Summary:
I am writing to ask the following questions about individuals living with Functional Neurological Disorder (FND) in your Health Board area, which may also be recorded under the ICD-10 classification system as section F44 Dissociative and Conversion Disorders and the associated subsections. · Could you please respond as to how many individual persons of any age that are registered with a GP practice in your Health Board area as of 1st December 2025 that have been potentially or actually confirmed as having a diagnosis of Functional neurological disorder on their medical records either by naming the diagnosis as Functional neurological disorder, FND or recording under the ICD-10 classification of section F44 Dissociative and Conversion Disorders or categories thereunder (F44.4, F44.5, F44.6, F44.7 or F44.9). If you are trialling using the ICD-11 classification system at present I would be obliged if you used the appropriate coding classification. · Please indicate the number of individual persons that have been diagnosed or potentially diagnosed with FND or dissociative/conversion disorder by a neurologist in your Health Board area or by a specialist referral to another Board in the following tax years: 2020/2021 2021/2022 2022/2023 2023/2024
Date of Response: 30/01/2026
View Response: 11014.pdf
Freedom of Information Request Reference: 11013
Date Received: 07/01/2026
Summary:
I wish to make a Freedom of Information Request for the number of cancelled operations in 2020, 2021, 2022, 2023, 2024 & 2025.
Date of Response: 30/01/2026
View Response: 11013.pdf
Freedom of Information Request Reference: 11005
Date Received: 05/01/2026
Summary:
1. Where a child receives a private diagnosis of ADHD or a similar neurodevelopmental condition, does NHS Lothian recognise that diagnosis for the purposes of NHS prescribing? o Specifically, is the child or adult eligible for NHS prescriptions without requiring a repeat NHS assessment? 2. Does NHS Lothian have a formal policy regarding shared care arrangements following private diagnoses? o If so, please provide a copy. o If not, is any such policy currently under development? 3. Are GP practices within NHS Lothian required or encouraged to accept shared care agreements for children diagnosed privately? o If not, what guidance is provided to practices to support continuity of care? 4. Does NHS Lothian hold any information on which GP practices currently accept shared care arrangements for private ADHD diagnoses? o If such a list exists, please provide it. o If no list exists, what steps is the Board taking to improve transparency and communication for families seeking care? 5. What action is NHS Lothian taking to ensure that children with private diagnoses are not left without access to medication or monitoring, particularly in cases where their GP practice is unable to prescribe? 6. What policy advice has the Board received from the Scottish Government on this issue?
Date of Response: 10/02/2026
View Response: 11005.pdf
Freedom of Information Request Reference: 11000
Date Received: 05/01/2026
Summary:
I am writing to gather information regarding Adenomyosarcoma of the uterus: 1) How many procedures are performed for Adenomyosarcoma of the uterus annually in the gynaecology department within NHS Lothian? 2) What are the 5 Year survival outcomes?
Date of Response: 10/02/2026
View Response: 11000.pdf
Freedom of Information Request Reference: 10952
Date Received: 12/12/2025
Summary:
1.How many sexual safety incidents took place in trust premises since 1 Jan 2020 to date? 2.Please provide a breakdown of the total provided in question 1 by calendar year* (2020-to date) 3.Please provide a breakdown of the total provided in question 1 by type of sexual safety incident - e.g. a) rape, b) sexual assault etc 4.Please provide a breakdown of the total provided in question 1 by age of victim in the following categories: a) under 18, b) 18-64 and c) 65 and over** 5.Please provide a breakdown of the total provided in question 1 by status of the victim and perpetrator in the following categories: a. Perpetrator was a staff member and victim was staff member b. Perpetrator was a member of the public (or patient) and victim was a member of the public (or patient) c. Perpetrator was a member of the public (or patient) and victim was a staff member d. Perpetrator was a staff member and victim was a member of the public (or patient) 6.Please provide a breakdown of the total number of rapes since 1 Jan 2020 (i.e. the answer to 3.a) by the age of the rape victim in the following categories: a) under 18, b) 18-64 and c) 65 plus** 7. Does your trust have a dedicated policy to deal with sexual assault and harassment? If so please provide a copy of your trust’s written policy and if possible provide a date that the current policy was put in place.
Date of Response: 22/01/2026
View Response: 10952-1.pdf
Freedom of Information Request Reference: 10904
Date Received: 03/12/2025
Summary:
Under the FoI Act please provide the following information for Medical Staff by grade at the Royal Edinburgh Hospital Eden Ward Authorised and Actual levels by shift weekly for the period 1 February to 30 October 2025.
Date of Response: 06/02/2026
View Response: 10904.pdf
Freedom of Information Request Reference: 11011
Date Received: 07/01/2026
Summary:
What quantity of 10 % Dextrose with 0.15 % KCl was used in WGH during the last 6 months? ( I'd be happy for an answer relating to any defined period of more than a month and up to one year - whatever is easiest for you to answer. The timing of this could be anytime in the last two years). Same question for 10 % Dextrose on its own. Same question for any prepared infusions containing 0.15 % KCl.
Date of Response: 02/02/2026
View Response: 11011.pdf
Freedom of Information Request Reference: 11010
Date Received: 07/01/2026
Summary:
Question One: How many patients has your trust treated in the past six months (for any disease) with the following drugs: Aubagio (teriflunomide) Avonex (interferon beta-1a) Betaferon (interferon beta-1b) Brabio (glatiramer acetate) Copaxone (glatiramer acetate) Extavia (beta interferon-1b) Gilenya (fingolimod) Kesimpta (ofatumumab) Lemtrada (alemtuzumab) Mavenclad (cladribine) Mayzent (siponimod) Ocrevus (ocrelizumab) Plegridy (peginterferon beta-1a) Ponvory (ponesimod) Rebif (beta interferon-1a) Tecfidera (dimethyl fumarate) Tysabri (natalizumab) Tysabri (natalizumab) Pre-filled syringes only Vumerity (diroximel fumarate) Zeposia (ozanimod) Fingolimod generic Tyruko (Natalizumab Biosimilar) Briumvi (ublituximab) Question Two: How many patients has your trust treated with Rituximab for MS (Multiple Sclerosis) in the past six months? Question Three: How many patients within your trust have a diagnosis of MS (Multiple Sclerosis)?
Date of Response: 30/01/2026
View Response: 11010.pdf
Freedom of Information Request Reference: 11009
Date Received: 06/01/2026
Summary:
I would be grateful if you could provide copies of NHS Lothian’s current internal policies, procedures, guidance documents, or process maps relating to: 1.The internal process for referring a patient from one clinical department to another within NHS Lothian; and specifically 2. The internal process for referral to Ophthalmology; and 3. The internal process for referral to Neurosurgery within the Department of Clinical Neurosciences (or its current equivalent).
Date of Response: 03/02/2026
View Response: 11009.pdf
Freedom of Information Request Reference: 11008
Date Received: 06/01/2026
Summary:
I would like to request the following information for your healthcare trust during the period 1st Jan2015 to 31st December 2025: 1. Annual number of patients diagnosed with blood cancers per year overall, and by subtype: • Lymphomas (C81-86) • Malignant immunoproliferative diseases (C88) • Multiple myeloma and malignant plasma cell neoplasms (C90) • Leukaemia (C91-C95) • Unspecified malignant neoplasms of lymphoid, haematopoietic and related tissues (C96) 2. The number of blood cancer clinical trials available, including active trials that are recruiting and trials that are not actively recruiting. 3. Annual number of patients who were enrolled in interventional or observational clinical trials related to these blood cancers per year. 4. The scientific title, clinical trial registration number, phase (I/II/III/IV/other), opening and closing recruitment dates, number recruited at this trust, and location of each trial related to blood cancer. 5. The current number of dedicated research staff (e.g. research nurses, research practitioners, study coordinators etc.) assigned to haematological clinical trials. 6. If available, annual counts of invitations/offers made to eligible patients to consider trial participation.
Date of Response: 03/02/2026
View Response: 11008.pdf
Freedom of Information Request Reference: 11007
Date Received: 06/01/2026
Summary:
I am writing to you under the Freedom of Information Act to request information on the following public sector contracts procured: 1. https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=NOV399947 Please can you let me know the following: • What is the total value of this contract? • What is the total length of the contract/or what is the expiry date?
Date of Response: 29/01/2026
View Response: 11007.pdf
Freedom of Information Request Reference: 11006
Date Received: 06/01/2026
Summary:
1) Has your organisation purchased implantable ports in the last 3 years? 2) If yes, to question 1, please can you kindly provide a purchasing export report detailing the following relevant to implantable ports for the time periods stated and name the files according to the financial year, including all supply routes. Time Periods ▪ 1st April 2022 – 31st March 2023 ▪ 1st April 2023 – 31st March 2024 ▪ 1st April 2024 – 31st March 2025 3) If yes, to question 1, please mark with an ‘x’ which clinicians/clinical areas implant ports: Surgeons Anaesthetists Interventional Radiology Vascular Access Nurses Other (Please State)
Date of Response: 28/01/2026
View Response: 11006.pdf
Freedom of Information Request Reference: 11003
Date Received: 06/01/2026
Summary:
In the period 1st October 2025 to 31st December 2025 please provide a breakdown of: • Total trust spend with framework agencies for locum nurses Please provide a further breakdown for locum nurses by: • Spend per band • Spend per specialty • Spend per agency name In the period 1st October 2025 to 31st December 2025 please provide a breakdown of: • Total trust spend with off framework agencies for locum nurses Please provide a further breakdown for locum nurses by: • Spend per band • Spend per specialty • Spend per agency name In the period 1st October 2025 to 31st December 2025 please provide a breakdown of: • Total trust spend with the internal trust bank or associated external provider for locum nurses Please provide a further breakdown for locum nurses by: • Spend per band • Spend per specialty • Spend per agency name Please confirm the total number of nursing shifts booked during this period for all agency nursing only, no bank staff nursing to be included (1st October 2025 to 31st December 2025) Please confirm the total number of nursing shifts booked above NHSE capped rates during this period for all agency nursing only, no bank staff nursing to be included (1st October 2025 to 31st December 2025) Please confirm the framework you utilise for nursing agency staff.
Date of Response: 29/01/2026
View Response: 11003.pdf
Freedom of Information Request Reference: 11001
Date Received: 05/01/2026
Summary:
Number of shifts booked by ON Framework agency staff broken down by provider and month from January 2025 To December 31st 2025 Number of shifts booked by OFF Framework agency staff broken down by provider and month from January 2025 To December 31st 2025 Total spend on ON Framework agency staff broken down by agency and month from January 2025 To December 31st 2025 Total spend on OFF Framework agency staff broken down by agency and month from January 2025 To December 31st 2025
Date of Response: 29/01/2026
View Response: 11001.pdf
Freedom of Information Request Reference: 10999
Date Received: 05/01/2026
Summary:
Please provide the following information for December 2024 to November 2025, financial year 2024/25, or the most recent 12 month period available: 1. Scan volume Total number of lower limb duplex or Doppler ultrasound scans performed for suspected deep vein thrombosis (DVT). 2. Waiting times a) Average time from order to completion, or request to scan completion, whichever your systems record. b) If recorded, the number or percentage of patients who received their scan within: i. 4 hours ii. between 4 and 24 hours iii. between 24 and 48 hours iv. more than 48 hours after request (for example: X% within 4 hours, Y% between 4 and 24 hours, Z% more than 48 hours, etc). 3. Overnight admissions Number admitted overnight specifically to await their scan, if recorded.
Date of Response: 29/01/2026
View Response: 10999.pdf
Freedom of Information Request Reference: 10997
Date Received: 05/01/2026
Summary:
1) For the year 1st January 2025 - 31st December 2025 the total number of circumcisions performed for all age ranges at NHS Lothian. 2) For the year 1st January 2025 - 31st December 2025 the total number of circumcisions performed for all age ranges at NHS Lothian using general anaesthesia. 3) For the year 1st January 2025 - 31st December 2025 the total number of circumcisions performed for all age ranges at NHS Lothian using local anaesthesia. 4) For the year 1st January 2025 - 31st December 2025 the total number of circumcisions performed for therapeutic reasons for all age ranges using general anaesthesia at NHS Lothian. 5) For the year 1st January 2025 - 31st December 2025 the total number of circumcisions performed for therapeutic reasons for all age ranges using local anaesthesia at NHS Lothian. 6) For the year 1st January 2025 - 31st December 2025 the total number of circumcisions performed for religious and cultural using general anaesthesia at NHS Lothian. 7) For the year 1st January 2025 - 31st December 2025 the total number of circumcisions performed for religious and cultural reasons using local anaesthesia at NHS Lothian.
Date of Response: 29/01/2026
View Response: 10997.pdf
Freedom of Information Request Reference: 10994
Date Received: 05/01/2026
Summary:
1: Can you advise does the trust use plain or printed cable ties ?, even if you use them for other operations , if not would you consider starting to use them if a amicable budget can be found ? 2: What would be your annual usage ? 3: Can you advise the current price paid per thousand ?, if this is sensitive information please advise the price you would like to pay to fit your budget. 4: Advise the size of tie , colour and print required ?, we do offer a generic print or you can have department and wards to streamline waste better . 5: Name and email of the current waste manager 6: Address for samples if required . 7: Would bio degradable be of interest ? 8: who is your current supplier?, and are you under contract.
Date of Response: 29/01/2026
View Response: 10994.pdf
Freedom of Information Request Reference: 10991
Date Received: 31/12/2025
Summary:
I would be very grateful if you could provide the following information: 1. The name and role title of the current Clinical Lead (or equivalent senior clinical leadership role) for: - Ophthalmology - Diagnostic and Clinical Neurosciences (DCN) 2. The date from which each individual has held that role. 3. If applicable, the name of the previous Clinical Lead for each department and the date their term ended.
Date of Response: 29/01/2026
View Response: 10991.pdf
Freedom of Information Request Reference: 10990
Date Received: 30/12/2025
Summary:
Review request in relation to staff appraisal.
Date of Response: 27/01/2026
View Response: 10990.pdf
Freedom of Information Request Reference: 10989
Date Received: 31/12/2025
Summary:
1. Is Remifentanil PCA offered in all intrapartum settings in your health board, if not, which units is it offered? 2. Is Remifentanil PCA routinely available, offered on request, or available only under specific circumstances? 3. If possible, could you also provide any relevant clinical guidelines or criteria used to determine eligibility for remifentanil PCA in labour? 4. When these guidelines were introduced in your health board?
Date of Response: 02/02/2026
View Response: 10989.pdf
Freedom of Information Request Reference: 10978
Date Received: 22/12/2025
Summary:
For the years 2024 and 2025 how many 1. Locum consultants 2. Substantive consultants who were employed by the Trust, or through a locum agency, and were NOT on a specialist register.
Date of Response: 29/01/2026
View Response: 10978.pdf
Freedom of Information Request Reference: 10965
Date Received: 15/12/2025
Summary:
Copies of all protocols and guidelines used by the Chalmer Gender Identity Clinic for which WPATH SOC7 or WPATH SOC8 have been used as guidelines for the medical or surgical management of patients, including any shared care agreements with GPs.
Date of Response: 29/01/2026
View Response: 10965.pdf
Freedom of Information Request Reference: 10952
Date Received: 12/12/2025
Summary:
1.How many sexual safety incidents took place in trust premises since 1 Jan 2020 to date? 2.Please provide a breakdown of the total provided in question 1 by calendar year* (2020-to date) 3.Please provide a breakdown of the total provided in question 1 by type of sexual safety incident - e.g. a) rape, b) sexual assault etc 4.Please provide a breakdown of the total provided in question 1 by age of victim in the following categories: a) under 18, b) 18-64 and c) 65 and over** 5.Please provide a breakdown of the total provided in question 1 by status of the victim and perpetrator in the following categories: a. Perpetrator was a staff member and victim was staff member b. Perpetrator was a member of the public (or patient) and victim was a member of the public (or patient) c. Perpetrator was a member of the public (or patient) and victim was a staff member d. Perpetrator was a staff member and victim was a member of the public (or patient) 6.Please provide a breakdown of the total number of rapes since 1 Jan 2020 (i.e. the answer to 3.a) by the age of the rape victim in the following categories: a) under 18, b) 18-64 and c) 65 plus** 7. Does your trust have a dedicated policy to deal with sexual assault and harassment? If so please provide a copy of your trust’s written policy and if possible provide a date that the current policy was put in place.
Date of Response: 22/01/2026
View Response: 10952.pdf
Freedom of Information Request Reference: 10943
Date Received: 11/12/2025
Summary:
For each financial year from 2019/20 to 2025/26 (most recent): 1. the total number of referrals for a hysterectomy 2. the median completed wait (in days) for a hysterectomy 3. the longest completed waited (in days) for a hysterectomy 4. the median ongoing wait (in days) for a hysterectomy 5. the longest ongoing wait (in days) for a hysterectomy
Date of Response: 30/01/2026
View Response: 10943.pdf
Freedom of Information Request Reference: 10942
Date Received: 11/12/2025
Summary:
For each financial year from 2019/20 to 2025/26 (most recent): 1. The total number of laparoscopy procedures performed on women 2. The median completed wait (in days) for a laparoscopy procedure performed on women 3. The longest completed wait (in days) for a laparoscopy procedure performed on women 4. The median ongoing wait (in days) for a laparoscopy procedure performed on women 5. The longest ongoing wait (in days) for a laparoscopy procedures performed on women
Date of Response: 30/01/2026
View Response: 10942.pdf
Freedom of Information Request Reference: 10909
Date Received: 04/12/2025
Summary:
Please state the operational capacity and design capacity for the emergency departments of each of the hospitals listed below. • Royal Hospital for Children and Young People • Royal Infirmary of Edinburgh • St John’s Hospital For the hospitals listed, please confirm, the actual capacity of each one on the 1st of each month this year (January to December 2025).
Date of Response: 05/02/2026
View Response: 10909.pdf
Freedom of Information Request Reference: 10906
Date Received: 03/12/2025
Summary:
1. The number of taxi journeys paid for by the health board to transport patients to and from hospital appointments, including A&E, for each financial year from 2019-20 to 2024-25. 2. The total cost of taxi journeys paid for by the health board to transport patients to and from hospital appointments, including A&E, for each financial year from 2019-20 to 2024-25. 3. The furthest individual taxi journey recorded in each of those years (2019-20 to 2024-25), including the start and end locations (or distance if preferred).
Date of Response: 06/01/2026
View Response: 10906.pdf
Carer Positive Icon
Awards Aware Icon
We are a Living wage Employer Icon
Duke of Edinburgh's Award Logo
Young Person's Guaranteed Employer Logo
Scottish Top Employers Logo
Disability Confident Employer Logo
 
CONTACT NHS LOTHIAN
Lothian NHS Board
Mainpoint
102 Westport
Edinburgh
EH3 9DN

Main Switchboard: 0131 242 1000
YOUR RIGHTS
OUR VALUES INTO ACTION
Around 3,000 colleagues across NHS Lothian have developed Our Values, a set of common values and ways of working - to the benefit of everyone working in the organisation and, most importantly - to the benefit of our patients.
WORKING WITH NHS LOTHIAN
MEDIA ENQUIRIES
STAY CONNECTED TO NHS LOTHIAN
Facebook
Twitter
YouTube
Vimeo
Instagram
PARTNERS